Molecular Partners
Z├╝rich
About Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. They are developing a powerful new class of potent, specific and versatile small protein therapies called DARPin® therapeutics.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $208.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2024)
- Ticker: six:MOLN
- Website: molecularpartners.com
- Phone: +41 44 755 77 00
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/molecular-partners-82431 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.